Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

1.480

-0.010 (-0.67%)

At close: Oct 15, 2026, 4:00 PM EDT

1.475

-0.005 (-0.34%)

After-hours: Oct 15, 2026, 7:59 PM EDT

Anavex Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	137	764	482	537	804	1,359
Market Cap Growth	-81.84%	58.72%	-10.27%	-33.27%	-40.83%	396.34%
Enterprise Value	19	663	343	382	651	1,202
Last Close Price	1.48	8.90	5.68	6.55	10.32	17.95

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Forward PE	-	10.73	-	-	-	-
PB Ratio	1.22	8.06	4.01	3.78	5.65	9.01
P/TBV Ratio	1.22	8.06	4.01	3.78	5.65	9.01

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Net Debt / Equity Ratio	-1.05	-1.08	-1.10	-1.06	-1.05	-1.01
Quick Ratio	15.51	11.56	8.80	12.27	14.92	14.93
Current Ratio	15.62	11.61	8.86	12.32	14.95	14.97
Return on Equity (ROE)	-12.80%	-43.11%	-32.81%	-33.41%	-32.71%	-42.58%
Return on Assets (ROA)	-9.70%	-26.51%	-21.81%	-21.59%	-18.95%	-23.87%
Return on Capital Employed (ROCE)	-15.40%	-53.50%	-42.10%	-37.40%	-33.40%	-24.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 15, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Earnings Yield	-9.49%	-6.07%	-8.93%	-8.85%	-5.96%	-2.79%
Buyback Yield / Dilution	-5.94%	-2.18%	-4.61%	-3.74%	-10.18%	-19.95%

SEC Filings: 10-K · 10-Q